Proxy Votes Now

Home › Activist investors › Third Point

Third Point

Campaign activist. Positions and campaigns from Third Point’s SEC filings. Updated November 20, 2026.

Filer entities
Third Point LLC
SEC CIK
1040273 (Third Point LLC)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Sep 30, 2026, filed Nov 16, 2026: 32 US-listed positions reported; 4 of 1% or more of a company without a 13D are listed below.
5current positions (plus 2 control positions)
5new or changed in 90 days
0active campaigns
4campaigns on record

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (7)

CompanyStakeSourceFirst disclosedLast changeSince previous filingFlagsStated intent
Third Point Private Capital Income Fund 100.0%161,000 shares Schedule 13D, filed Nov 5, 2026 Nov 5, 2026 — — Control positionNew Seeks changes or engagement
Third Point Private Capital Partners 64.8%1,933,159 shares Schedule 13D/A, filed Nov 5, 2026 Apr 14, 2026 Increased Nov 5, 2026 ▼ 11.80 pts Control positionIncreased Seeks changes or engagement
Strata Critical Medical, Inc. 5.8%5,126,511 shares Schedule 13D, filed Oct 15, 2026 Oct 15, 2026 — — New Seeks changes or engagement
Telephone and Data Systems, Inc. 3.78%4,300,000 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Mar 31, 2026 Nov 14, 2023 Decreased Nov 16, 2026 ▼ 1.73 pts Decreased 13F: none stated
Unum Group 3.23%5,000,000 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Nov 2, 2026 Nov 16, 2026 — — New 13F: none stated
APi Group Corporation 1.16%4,935,000 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Oct 22, 2026 Feb 17, 2026 Increased Nov 16, 2026 ▲ 0.50 pts Increased 13F: none stated
Hut 8 Corp. 1.09%1,224,500 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Mar 31, 2026 May 15, 2026 Decreased Nov 16, 2026 ▼ 0.08 pts Decreased 13F: none stated

Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.

Stated intent (13D Item 4)

Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.

Third Point Private Capital Income Fund · Seeks changes or engagement

“…without limitation, engaging advisors, including legal, financial, regulatory, technical and/or industry advisors, to assist in any review, and evaluating strategic alternatives as they may become available. The Advisor, a Delaware limited liability company and an affiliate of the Management Company, acts as the Issuer's investment adviser. The Advisor is an investment adviser registered with the SEC under the Investment Advisers Act of 1940, as amended…”

Item 4 in the Schedule 13D filed Nov 5, 2026.

Third Point Private Capital Partners · Seeks changes or engagement

“…without limitation, engaging advisors, including legal, financial, regulatory, technical and/or industry advisors, to assist in any review, and evaluating strategic alternatives as they may become available. The Advisor, a Delaware limited liability company and an affiliate of the Management Company, acts as the Issuer's investment adviser. The Advisor is an investment adviser registered with the SEC under the Investment Advisers Act of 1940, as amended…”

Item 4 in the Schedule 13D/A filed Nov 5, 2026; this amendment did not restate Item 4, so the text is from the filing of Apr 14, 2026.

Strata Critical Medical, Inc. · Seeks changes or engagement

“…business of the Issuer is strong, but not of a scale to support its current overhead and that management incentive options are not aligned with creating shareholder value. Accordingly, the Reporting Persons believe that the Issuer should explore strategic alternatives, including the consideration of a potential sale of the Issuer managed by a reputable investment banking firm. The Reporting Persons may communicate with the Issuer's management and/or…”

Item 4 in the Schedule 13D filed Oct 15, 2026.

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (4)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
Advance Auto Parts Inc Settled (agreement with the company) Mar 12, 2024 Mar 12, 2024 — latest (1) —
Campbell Soup CoBoard seats No campaign filings in the last 12 months Nov 20, 2018 Aug 9, 2018 Proxy contest filed latest (40) —
Dow Chemical Co /De/ No campaign filings in the last 12 months Nov 13, 2014 Nov 13, 2014 Soliciting material filed latest (2) —
SothebysBoard seats No campaign filings in the last 12 months May 1, 2014 Feb 27, 2014 Proxy contest filed latest (18) —
Past positions (3)
CompanyLast stakeSourceOutcomeDate
flyExclusive, Inc. 4.4% Schedule 13D/A, filed Jan 13, 2026 Reported below 5% in a 13D/A Jan 13, 2026
Soho House & Co Inc. 0.0% Schedule 13D/A, filed Aug 20, 2025 Exited Aug 20, 2025
Bath & Body Works, Inc. 3.6% Schedule 13D/A, filed Oct 25, 2024 Reported below 5% in a 13D/A Oct 25, 2024

How large managers voted in Third Point’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

1Settlement
3No outcome in the filings read
Outcome of each campaign (4)
CompanyOutcomeDetailDateFirst filing
Advance Auto Parts Inc Settlement agreement with the company Mar 12, 2024 Mar 12, 2024
Campbell Soup Co No outcome in the filings read — Nov 20, 2018 Aug 9, 2018
Dow Chemical Co /De/ No outcome in the filings read — Nov 13, 2014 Nov 13, 2014
Sothebys No outcome in the filings read — May 1, 2014 Feb 27, 2014

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 1 of 6 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

CompanyFirst 13DTo latest closeSPY same dates6 months after12 months after
Strata Critical Medical, Inc. SRTA Oct 15, 2026 +14.3%Oct 15, 2026 – Nov 18, 2026 -5.4% not yet / no price not yet / no price

Prices: daily closes (Nasdaq), as stored by the site.

Settlement terms

Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.

Advance Auto Parts Inc · Mar 12, 2024 · Standstill

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Third Point’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

Unum Group · Third Point first disclosed Nov 16, 2026 · 1 other filing
HolderFormDateStake
TOMS Capital 13F Aug 14, 2026 1.2%
Strata Critical Medical, Inc. · Third Point first disclosed Oct 15, 2026 · 4 other filings
HolderFormDateStake
ARK Investment Management LLC Schedule 13G Apr 30, 2026 8.6%
Northern Right Capital Management, L.P. Schedule 13G Jun 17, 2026 5.1%
Steele ExpCo Holdings, LLC Schedule 13G Aug 20, 2026 9.0%
Becker Drapkin 13F Nov 16, 2026 5.0%
Hut 8 Corp. · Third Point first disclosed May 15, 2026 · 4 other filings
HolderFormDateStake
Jane Street Group, LLC Schedule 13G Feb 2, 2026 2.0%
Lone Pine Capital LLC Schedule 13G Mar 6, 2026 5.6%
G1 Execution Services, LLC Schedule 13G May 15, 2026 2.7%
Vanguard Portfolio Management Schedule 13G Jul 31, 2026 5.6%
APi Group Corporation · Third Point first disclosed Feb 17, 2026 · 2 other filings
HolderFormDateStake
Janus Henderson Group PLC Schedule 13G Nov 14, 2025 5.3%
T. Rowe Price Associates, Inc. Schedule 13G Nov 14, 2025 4.8%
Bath & Body Works, Inc. · Third Point first disclosed Oct 25, 2024 · 1 other filing
HolderFormDateStake
BlackRock, Inc. Schedule 13G Apr 17, 2025 8.8%
flyExclusive, Inc. · Third Point first disclosed Feb 13, 2024 · 2 other filings
HolderFormDateStake
Hymowitz Gregg Schedule 13D Jan 8, 2024 86.0%
Segrave Thomas James Jr. Schedule 13D Jan 8, 2024 68.9%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.